Current status of the combined therapy for pancreatic cancer
10.3760/cma.j.issn.1673-9752.2009.04.001
- VernacularTitle:胰腺癌综合治疗的现状
- Author:
Quanxing NI
;
Ji LI
- Publication Type:Journal Article
- Keywords:
Pancreatic neoplasms;
Combined therapy
- From:
Chinese Journal of Digestive Surgery
2009;8(4):241-243
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic cancer is one of the worst digestive malignancies characterized by non-specific symptoms, rapid progression and high mortality. Despite great efforts that have been made in basic and clinical research, the prognosis remains poor with an overall 5-year survival rate of less than 5%. Complete surgical resection is the only curative treatment option, but the curative resectabillty is still about 15% in China. Pancreatic surgery is considered one of the most techni-cally demanding and challenging procedures. The development of pancreatic surgery in China depends not only on the progress in surgical techniques, but also the specialization on pancreatic surgery. There has been advancement in combined therapy with a modern interdisciplinary approach including chemotherapy,radiotherapy, biotherapy and thermotherapy. The research pro-gress of gene therapy on pancreatic cancer showed us some hopes for the future. The outcome of pancreatic cancer treated by Chinese medicine with herbal drugs is encouraging, but still needs the support of more solid evidences from randomized con-trolled trials. It is suggested that the combined therapy should play an important role in the treatment of pancreatic cancer, and the fallow-up should be paid more attention.
